Details for New Drug Application (NDA): 213206
✉ Email this page to a colleague
The generic ingredient in VASOPRESSIN is vasopressin. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the vasopressin profile page.
Summary for 213206
Tradename: | VASOPRESSIN |
Applicant: | Fresenius Kabi Usa |
Ingredient: | vasopressin |
Patents: | 0 |
Pharmacology for NDA: 213206
Physiological Effect | Decreased Diuresis Vasoconstriction |
Suppliers and Packaging for NDA: 213206
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VASOPRESSIN | vasopressin | SOLUTION;INTRAVENOUS | 213206 | ANDA | Fresenius Kabi USA, LLC | 63323-930 | 63323-930-01 | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-930-01) / 1 mL in 1 VIAL, SINGLE-DOSE (63323-930-00) |
VASOPRESSIN | vasopressin | SOLUTION;INTRAVENOUS | 213206 | ANDA | Fresenius Kabi USA, LLC | 65219-039 | 65219-039-01 | 25 VIAL, SINGLE-DOSE in 1 TRAY (65219-039-01) / 1 mL in 1 VIAL, SINGLE-DOSE (65219-039-00) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 20UNITS/ML (20UNITS/ML) | ||||
Approval Date: | May 26, 2023 | TE: | AP | RLD: | No |
Complete Access Available with Subscription